ID   GLRA1_RAT               Reviewed;         457 AA.
AC   P07727; Q546L6;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   08-DEC-2000, sequence version 4.
DT   29-MAY-2024, entry version 204.
DE   RecName: Full=Glycine receptor subunit alpha-1;
DE   AltName: Full=Glycine receptor 48 kDa subunit;
DE   AltName: Full=Glycine receptor strychnine-binding subunit;
DE   Flags: Precursor;
GN   Name=Glra1; Synonyms=Glyr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, TRANSPORTER ACTIVITY,
RP   SUBCELLULAR LOCATION, AND ACTIVITY REGULATION.
RX   PubMed=1716350; DOI=10.1016/0168-0102(91)90064-6;
RA   Akagi H., Hirai K., Hishinuma F.;
RT   "Functional properties of strychnine-sensitive glycine receptors expressed
RT   in Xenopus oocytes injected with a single mRNA.";
RL   Neurosci. Res. 11:28-40(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND ALTERNATIVE SPLICING.
RC   STRAIN=Wistar; TISSUE=Spinal cord;
RX   PubMed=1703526; DOI=10.1016/s0021-9258(18)52207-9;
RA   Malosio M.L., Grenningloh G., Kuhse J., Schmieden V., Schmitt B., Prior P.,
RA   Betz H.;
RT   "Alternative splicing generates two variants of the alpha 1 subunit of the
RT   inhibitory glycine receptor.";
RL   J. Biol. Chem. 266:2048-2053(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11981023; DOI=10.1085/jgp.20028530;
RA   Beato M., Groot-Kormelink P.J., Colquhoun D., Sivilotti L.G.;
RT   "Openings of the rat recombinant alpha 1 homomeric glycine receptor as a
RT   function of the number of agonist molecules bound.";
RL   J. Gen. Physiol. 119:443-466(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-30, FUNCTION, TRANSPORTER ACTIVITY,
RP   ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=2483325; DOI=10.1016/0896-6273(89)90195-5;
RA   Sontheimer H., Becker C.M., Pritchett D.B., Schofield P.R., Grenningloh G.,
RA   Kettenmann H., Betz H., Seeburg P.H.;
RT   "Functional chloride channels by mammalian cell expression of rat glycine
RT   receptor subunit.";
RL   Neuron 2:1491-1497(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-457 (ISOFORM B), PROTEIN SEQUENCE OF
RP   29-49, FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar;
RX   PubMed=3037383; DOI=10.1038/328215a0;
RA   Grenningloh G., Rienitz A., Schmitt B., Methfessel C., Zensen M.,
RA   Beyreuther K., Gundelfinger E.D., Betz H.;
RT   "The strychnine-binding subunit of the glycine receptor shows homology with
RT   nicotinic acetylcholine receptors.";
RL   Nature 328:215-220(1987).
RN   [6]
RP   SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=6286620; DOI=10.1016/s0021-9258(18)34082-1;
RA   Pfeiffer F., Graham D., Betz H.;
RT   "Purification by affinity chromatography of the glycine receptor of rat
RT   spinal cord.";
RL   J. Biol. Chem. 257:9389-9393(1982).
RN   [7]
RP   STRYCHNINE BINDING SITE.
RX   PubMed=2171639; DOI=10.1021/bi00482a012;
RA   Ruiz-Gomez A., Morato E., Garcia-Calvo M., Valdivieso F., Mayor F. Jr.;
RT   "Localization of the strychnine binding site on the 48-kilodalton subunit
RT   of the glycine receptor.";
RL   Biochemistry 29:7033-7040(1990).
RN   [8]
RP   INTERACTION WITH GLRB.
RX   PubMed=14551753; DOI=10.1007/s00249-003-0286-y;
RA   Mohammadi B., Krampfl K., Cetinkaya C., Moschref H., Grosskreutz J.,
RA   Dengler R., Bufler J.;
RT   "Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta
RT   glycine receptor channels.";
RL   Eur. Biophys. J. 32:529-536(2003).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels. Channel
CC       opening is triggered by extracellular glycine (PubMed:11981023,
CC       PubMed:1716350, PubMed:2483325, PubMed:3037383). Channel opening is
CC       also triggered by taurine and beta-alanine (PubMed:1716350). Channel
CC       characteristics depend on the subunit composition; heteropentameric
CC       channels are activated by lower glycine levels and display faster
CC       desensitization. Plays an important role in the down-regulation of
CC       neuronal excitability. Contributes to the generation of inhibitory
CC       postsynaptic currents. Channel activity is potentiated by ethanol (By
CC       similarity). Potentiation of channel activity by intoxicating levels of
CC       ethanol contribute to the sedative effects of ethanol (By similarity).
CC       {ECO:0000250|UniProtKB:P23415, ECO:0000250|UniProtKB:Q64018,
CC       ECO:0000269|PubMed:11981023, ECO:0000269|PubMed:1716350,
CC       ECO:0000269|PubMed:2483325, ECO:0000269|PubMed:3037383}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:11981023,
CC         ECO:0000269|PubMed:1716350, ECO:0000269|PubMed:2483325,
CC         ECO:0000269|PubMed:3037383};
CC   -!- ACTIVITY REGULATION: Inhibited by strychnine (PubMed:1716350,
CC       PubMed:2483325, PubMed:3037383). Inhibited by picrotoxin
CC       (PubMed:2483325). {ECO:0000269|PubMed:1716350,
CC       ECO:0000269|PubMed:2483325, ECO:0000269|PubMed:3037383}.
CC   -!- SUBUNIT: Homopentamer (in vitro). Interacts with GLRB to form
CC       heteropentameric channels; this is probably the predominant form in
CC       vivo. Heteropentamer composed of two GLRA1 and three GLRB.
CC       Heteropentamer composed of three GLRA1 and two GLRB. Both homopentamers
CC       and heteropentamers form functional ion channels, but their
CC       characteristics are subtly different. Interacts with GLRB (By
CC       similarity). {ECO:0000250|UniProtKB:P23415,
CC       ECO:0000269|PubMed:6286620}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000305|PubMed:6286620}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q64018}. Synapse {ECO:0000269|PubMed:6286620}.
CC       Perikaryon {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q64018}. Cell membrane
CC       {ECO:0000269|PubMed:11981023, ECO:0000269|PubMed:1716350,
CC       ECO:0000269|PubMed:2483325, ECO:0000269|PubMed:3037383}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:P23415}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a; Synonyms=Long;
CC         IsoId=P07727-1; Sequence=Displayed;
CC       Name=b; Synonyms=Short;
CC         IsoId=P07727-2; Sequence=VSP_000081;
CC   -!- TISSUE SPECIFICITY: Detected in spinal cord (at protein level)
CC       (PubMed:2483325, PubMed:6286620). Detected in spinal cord and brain
CC       stem (PubMed:3037383). {ECO:0000269|PubMed:2483325,
CC       ECO:0000269|PubMed:3037383, ECO:0000269|PubMed:6286620}.
CC   -!- DOMAIN: The channel pore is formed by pentameric assembly of the second
CC       transmembrane domain from all five subunits. Channel opening is
CC       effected by an outward rotation of the transmembrane domains that
CC       increases the diameter of the pore. {ECO:0000250|UniProtKB:O93430}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:2171639, ECO:0000269|PubMed:3037383,
CC       ECO:0000269|PubMed:6286620}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Glycine receptor (TC 1.A.9.3) subfamily. GLRA1 sub-subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D00833; BAA00707.1; -; mRNA.
DR   EMBL; X55246; CAA38987.1; -; mRNA.
DR   EMBL; M63915; AAA63490.1; -; mRNA.
DR   EMBL; AJ310835; CAC35979.1; -; mRNA.
DR   EMBL; Y00276; CAA68378.1; -; mRNA.
DR   PIR; JN0014; JN0014.
DR   PIR; S20662; S20662.
DR   RefSeq; NP_037265.1; NM_013133.1. [P07727-2]
DR   RefSeq; XP_006246440.1; XM_006246378.3. [P07727-1]
DR   AlphaFoldDB; P07727; -.
DR   BMRB; P07727; -.
DR   SMR; P07727; -.
DR   CORUM; P07727; -.
DR   DIP; DIP-48879N; -.
DR   IntAct; P07727; 2.
DR   STRING; 10116.ENSRNOP00000063384; -.
DR   BindingDB; P07727; -.
DR   ChEMBL; CHEMBL3246; -.
DR   DrugCentral; P07727; -.
DR   GlyCosmos; P07727; 1 site, No reported glycans.
DR   GlyGen; P07727; 1 site.
DR   iPTMnet; P07727; -.
DR   PhosphoSitePlus; P07727; -.
DR   PaxDb; 10116-ENSRNOP00000063384; -.
DR   Ensembl; ENSRNOT00000063889.4; ENSRNOP00000063384.3; ENSRNOG00000013588.8. [P07727-2]
DR   GeneID; 25674; -.
DR   KEGG; rno:25674; -.
DR   UCSC; RGD:2704; rat. [P07727-1]
DR   AGR; RGD:2704; -.
DR   CTD; 2741; -.
DR   RGD; 2704; Glra1.
DR   VEuPathDB; HostDB:ENSRNOG00000013588; -.
DR   eggNOG; KOG3644; Eukaryota.
DR   GeneTree; ENSGT00940000159047; -.
DR   InParanoid; P07727; -.
DR   OrthoDB; 4265336at2759; -.
DR   PhylomeDB; P07727; -.
DR   Reactome; R-RNO-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P07727; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000013588; Expressed in cerebellum and 3 other cell types or tissues.
DR   ExpressionAtlas; P07727; baseline and differential.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0060077; C:inhibitory synapse; ISO:RGD.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0016934; F:extracellularly glycine-gated chloride channel activity; IDA:RGD.
DR   GO; GO:0016933; F:extracellularly glycine-gated ion channel activity; IDA:RGD.
DR   GO; GO:0016594; F:glycine binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0030977; F:taurine binding; ISS:UniProtKB.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0007340; P:acrosome reaction; ISO:RGD.
DR   GO; GO:0007628; P:adult walking behavior; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; ISS:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; IDA:RGD.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0006820; P:monoatomic anion transport; IDA:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; ISS:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; ISS:UniProtKB.
DR   GO; GO:0051970; P:negative regulation of transmission of nerve impulse; ISS:UniProtKB.
DR   GO; GO:0050905; P:neuromuscular process; ISO:RGD.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISS:UniProtKB.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; ISO:RGD.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; ISO:RGD.
DR   GO; GO:0097305; P:response to alcohol; ISS:UniProtKB.
DR   GO; GO:0060013; P:righting reflex; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISS:UniProtKB.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IDA:RGD.
DR   GO; GO:0007601; P:visual perception; ISO:RGD.
DR   CDD; cd19009; LGIC_ECD_GlyR_alpha; 1.
DR   CDD; cd19060; LGIC_TM_GlyR_alpha; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008128; Glycine_rcpt_A1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF213; GLYCINE RECEPTOR SUBUNIT ALPHA-1; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01674; GLYRALPHA1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Metal-binding; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport; Zinc.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000269|PubMed:3037383"
FT   CHAIN           29..457
FT                   /note="Glycine receptor subunit alpha-1"
FT                   /id="PRO_0000000414"
FT   TOPO_DOM        29..250
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TRANSMEM        251..272
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TOPO_DOM        273..277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TRANSMEM        278..298
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TOPO_DOM        299..309
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TRANSMEM        310..330
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TOPO_DOM        331..425
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TRANSMEM        426..446
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   TOPO_DOM        447..457
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   BINDING         220
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         222
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         230..235
FT                   /ligand="strychnine"
FT                   /ligand_id="ChEBI:CHEBI:90700"
FT                   /evidence="ECO:0000250|UniProtKB:O93430,
FT                   ECO:0000305|PubMed:2171639"
FT   BINDING         243
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   SITE            289
FT                   /note="Important for obstruction of the ion pore in the
FT                   closed conformation"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   DISULFID        166..180
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   DISULFID        226..237
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   VAR_SEQ         354..361
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000303|PubMed:1716350,
FT                   ECO:0000303|PubMed:3037383"
FT                   /id="VSP_000081"
FT   CONFLICT        26
FT                   /note="A -> V (in Ref. 5; CAA68378)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   457 AA;  52617 MW;  0379C33A83C71FAA CRC64;
     MYSFNTLRFY LWETIVFFSL AASKEADAAR SAPKPMSPSD FLDKLMGRTS GYDARIRPNF
     KGPPVNVSCN IFINSFGSIA ETTMDYRVNI FLRQQWNDPR LAYNEYPDDS LDLDPSMLDS
     IWKPDLFFAN EKGAHFHEIT TDNKLLRISR NGNVLYSIRI TLTLACPMDL KNFPMDVQTC
     IMQLESFGYT MNDLIFEWQE QGAVQVADGL TLPQFILKEE KDLRYCTKHY NTGKFTCIEA
     RFHLERQMGY YLIQMYIPSL LIVILSWISF WINMDAAPAR VGLGITTVLT MTTQSSGSRA
     SLPKVSYVKA IDIWMAVCLL FVFSALLEYA AVNFVSRQHK ELLRFRRKRR HHKSPMLNLF
     QDDEGGEGRF NFSAYGMGPA CLQAKDGISV KGANNNNTTN PAPAPSKSPE EMRKLFIQRA
     KKIDKISRIG FPMAFLIFNM FYWIIYKIVR REDVHNK
//
